Josh Wolfe

Background

Josh Wolfe was raised in Coney Island, Brooklyn, New York City, by a single mother who worked as a public school teacher ¹². He graduated from the Dyson School of Applied Economics and Management at Cornell University in 1999 with a B.S. in Finance ¹². Prior to founding Lux, he was a Westinghouse Science Talent Search semi-finalist and published AIDS-immunopathology research in Cell Vision and The Journal of Leukocyte Biology ¹. He began his finance career in investment banking at Salomon Smith Barney and capital markets at Merrill Lynch ¹.

In 2000, Wolfe co-founded Lux Capital with Peter Hebert and Robert Paull to invest in scientists and entrepreneurs pursuing counter-conventional solutions to complex technical problems ¹². As of January 2026, Lux Capital manages approximately $7 billion in assets across nine funds, with Fund IX closing at $1.5 billion — the firm’s largest to date ³⁴.

In 2008, Wolfe co-founded and funded Kurion, a company using advanced robotics and engineering to clean up nuclear waste. Kurion responded to the Fukushima Daiichi disaster and was acquired by Veolia in February 2016 for approximately $365-400 million — roughly 34 times Lux’s total investment ¹⁵.

Wolfe has been invited to the White House and Capitol Hill to advise on nanotechnology and emerging technologies ¹. He is a Forbes columnist and was editor of the Forbes/Wolfe Emerging Tech Report ¹. He serves as a term member of the Council on Foreign Relations, a Trustee of the Santa Fe Institute, and Chairman of Coney Island Prep charter school ¹².

Stated Thesis

(Self-reported: These represent what Wolfe says publicly about his investing approach. See Inferred Thesis for analysis of actual investment behavior.)

Wolfe’s publicly stated investment philosophy centers on several core principles:

• “Directional arrows of progress”: Wolfe describes looking for observable trends in technology that indicate where progress is headed. He states: “When you can spot a directional arrow of progress, it increases the probability you’ll be right about a subsector.” He notes it “doesn’t point to who the entrepreneur is or what specific company it is, but it tells you with a reasonably high level of confidence where things are headed” ⁶.

• The shrinking gap between sci-fi and sci-fact: Wolfe has stated: “I’m looking for things that feel like they were once written about in science fiction” and “The gap between ‘sci-fi’ and ‘sci-fact’ is shrinking” ⁵.

• Backing rebel scientists: Wolfe seeks founders he describes as “PHDs — poor, hungry, and driven” and looks for “rebel scientists” with contrarian ideas where conventional wisdom says something will never work ⁵⁷.

• Risk-killing, not risk-taking: Wolfe has stated: “The very best entrepreneurs are risk-killers” and “There is a narrative fallacy that entrepreneurs are great risk-takers” ⁵.

• Failure imagination: Wolfe emphasizes the importance of anticipating failure: “Failure comes from a failure to imagine failure” and “The first thing I tell people when I make an investment, or I join the board, is, ‘I want the bad news’” ⁷.

• The “half-life of technology intimacy”: Wolfe observes technology becoming increasingly intimate with the human body — from mainframes to PCs to laptops to smartphones to wearables to neural interfaces — and invests along that trajectory ⁶.

Inferred Thesis

The analysis below is based on 24 verified Lux Capital portfolio investments where Wolfe’s involvement is confirmed or strongly implied through his board seats, directorship, or public statements. This represents a partial view — Lux has made hundreds of investments across nine funds, and Wolfe’s individual attribution is not always clear.

Sector concentration (based on 24 verified investments): - Defense / aerospace / autonomy: 5 of 24 (21%) — Anduril, Hadrian, Saildrone, Terra Industries, Echodyne - AI / machine learning / compute: 5 of 24 (21%) — Hugging Face, Runway, MosaicML, Cognition, Applied Compute - Biotech / life sciences: 5 of 24 (21%) — Eikon Therapeutics, Kallyope, Aera Therapeutics, Variant Bio, A-Alpha Bio - Robotics / hardware / manufacturing: 3 of 24 (13%) — Auris Health, Impulse Labs, Physical Intelligence - Energy / nuclear: 2 of 24 (8%) — Kurion, Osmo - Enterprise / fintech: 2 of 24 (8%) — Ramp, Erebor - Space / earth observation: 2 of 24 (8%) — Planet, Matterport

Key patterns:

• Deep-tech dominance confirmed: The portfolio is overwhelmingly deep-tech focused, consistent with Wolfe’s stated thesis. Virtually every investment involves proprietary technology with significant R&D barriers — no consumer social apps or marketplace businesses.

• Stage distribution: Lux invests primarily at seed and Series A, with typical check sizes of $1M-$50M and a target of $10M at early stage, scaling to $25M median for Fund IX ⁴⁸.

• Defense tech as a major vertical: 5 of 24 verified investments (21%) are in defense and aerospace. Wolfe has been vocal about the need for defense modernization and led Lux’s Series A in Anduril, now valued at $30.5 billion ⁵⁹.

• Dual-coast presence: Lux invests in companies based in both New York and the San Francisco Bay Area ⁸.

• Board-heavy involvement: Wolfe serves as a director on many portfolio company boards, including Aera Therapeutics, Cajal Neuroscience, Eikon Therapeutics, Impulse Labs, Kallyope, Osmo, and Variant Bio ¹.

• Co-investor patterns: Lux frequently co-invests with Founders Fund (Anduril), a16z (various), and leading biotech-focused firms. Key co-investors at Lux include Bilal Zuberi, Grace Isford, and Alex Nguyen ⁸.

• Notable exits: Kurion (acquired by Veolia, ~$365M, 34x return), Auris Health (acquired by J&J for up to $6.1B), MosaicML (acquired by Databricks for $1.3B), Matterport (acquired by CoStar 2025), CTRL-Labs (acquired by Facebook) ⁵¹⁰.

Portfolio

In Their Own Words

“The best way to predict the future is to invent it. If you accept the premise that the best way to predict the future is to invent it, the people who are inventing it are asymmetrically distributed.” — Josh Wolfe, The Knowledge Project podcast ⁷

“Almost everything that was ever invented, started with somebody saying, ‘Huh, that sucks. I’ve got a better idea.’” — Josh Wolfe, The Knowledge Project podcast ⁷

“At root, we are trying to find brilliant people and back them, and get really, really lucky.” — Josh Wolfe, The Knowledge Project podcast ⁷

“I really feel you waste so much time if you’re not direct and honest.” — Josh Wolfe, The Knowledge Project podcast ⁷

“Cultures get what they celebrate. One barometer of values is what children wish to be when they grow up. We don’t celebrate entrepreneurship and innovation like we used to.” — Josh Wolfe, Lux Capital investor letter, 2024 ¹¹

What Founders Say

No independently sourced founder testimonials found. Lux Capital’s website and press coverage reference portfolio company success stories but do not include direct founder quotes about working with Wolfe.

Sources